Red blood cell transfusion is associated with increased rebleeding in patients with nonvariceal upper gastrointestinal bleeding

Authors

  • S. Restellini,

    1. Department of Medical Specialities, Division of Gastroenterology and Hepatology, Geneva's University Hospitals and University of Geneva, Geneva, Switzerland
    Search for more papers by this author
  • O. Kherad,

    1. Department of Internal Medicine, La Tour Hospital and University of Geneva, Geneva, Switzerland
    Search for more papers by this author
  • V. Jairath,

    1. NHS Blood & Transplant and Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK
    Search for more papers by this author
  • M. Martel,

    1. Department of Medicine, Division of Gastroenterology, McGill University Health Center, McGill University, Montréal, QC, Canada
    Search for more papers by this author
  • A. N. Barkun

    Corresponding author
    1. Department of Medicine, Division of Gastroenterology, McGill University Health Center, McGill University, Montréal, QC, Canada
    2. Department of Epidemiology and Biostatistics and Occupational Health, McGill University Health Center, McGill University, Montréal, QC, Canada
    • Department of Medical Specialities, Division of Gastroenterology and Hepatology, Geneva's University Hospitals and University of Geneva, Geneva, Switzerland
    Search for more papers by this author

Correspondence to:

Dr A. N. Barkun, Division of Gastroenterology, The McGill University Health Center, Montreal General Hospital site, 1650 Cedar Avenue, room D16.125, Montréal H3G 1A4 Canada.

E-mail: alan.barkun@muhc.mcgill.ca

Summary

Background

There exists considerable practice variation and little evidence to guide red blood cell (RBC) transfusion in patients with nonvariceal upper gastrointestinal bleeding (NVUGIB). Studies in other critically ill cohorts suggest associations between transfusions and adverse patient outcomes.

Aim

To characterise any possible clinically-relevant association between RBC transfusion following NVUGIB with rebleeding and mortality.

Methods

Observational study utilising the Canadian Registry of patients with Upper Gastrointestinal Bleeding and Endoscopy (RUGBE). Multivariable logistic regression models were used to examine and quantify independent associations between RBC transfusion and clinical outcomes.

Results

Overall, 1677 patients were included (66.2 ± 16.8 years, 61.7% male, 2.5 ± 1.7 comorbid conditions, initial haemoglobin, 96.8 ± 27.2 g/L); 53.7% received RBC transfusions (2.9 ± 1.6 units of blood), 31.6% had haemodynamic instability, 5.1% fresh blood on rectal examination and 8.6% in the nasogastric tube aspirate. Endoscopic haemostasis was performed in 35.2%. Overall rebleeding (defined as continuous bleeding, rebleeding or surgery) and mortality rates were 17.9% and 5.4%, respectively. After adjusting for potential confounders, transfusion of RBC within 24 h of presentation was significantly and independently associated with an increased risk of rebleeding (OR: 1.8, 95% CI: 1.2–2.8), but not death (OR: 1.0, 95% CI: 0.6–1.8).

Conclusions

This study suggests an association between RBC transfusion following NVUGIB and subsequent rebleeding, after appropriate and extensive adjustment for confounding. Prospective randomised trial evidence is needed to identify the most efficacious and cost-effective transfusional strategies in these patients.

Ancillary